Stocks Hit Session Lows; Biotech, Homebuilders Lead Slump
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
Go back to Stocks Hit Session Lows; Biotech, Homebuilders Lead Slump
July 24, 2015 10:00 AM EDT
(Updated)
Sales of new single-family houses in June 2015 were at a seasonally adjusted annual rate of 482,000, said the U.S. Census Bureau and the Department of Housing and Urban Development. Data came in below the consensus of 548,000 and 6.8%... More
July 24, 2015 6:50 AM EDT
(Updated - July 24, 2015 6:51 AM EDT)
Biogen (Nasdaq: BIIB) reported Q2 adjusted EPS of $4.22, which was $0.12 better than the analyst estimate of $4.10. Revenue for the quarter came in at $2.59 billion versus the consensus estimate of $2.71 billion.
Neurology Highlights
In April 2015, the U.S. Food and Drug Administration accepted for review the Biologics License Application for ZINBRYTA for the treatment of relapsing forms of multiple sclerosis. ZINBRYTA is being jointly developed by Biogen and...
More
